ONWARD Medical N.V.: ONWARD Reports 2021 Full Year Financial

Company also provides Q1 2022 Business Update and 2022 Outlook ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence

Related Keywords

Boston , Massachusetts , United States , Netherlands , Switzerland , , International Financial Reporting Standards , Neither The Company , Company Employee Investment Plan , Company Financial , Drug Administration , Research Development , Pivotal Study For The Company , Company Operating Loss , Company Enquiries , Netherlands Authority For The Financial , Lausanne University Hospital , Home Study For The Company , Company Net Finance Expense , Annual Report , Netherlands Authority , Financial Markets , Breakthrough Device Designation , Euronext Brussels , Euronext Amsterdam , Operating Loss , Dave Marver , Market Access , Fees Related , Employee Investment Plan , Net Loss , Net Finance Expense , Bearing Loans , Interest Bearing Loans , Nature Medicine , Euronext Brussel Bel Small , Brain Spine Interface , Hemon Feasibility Study , Call Webcast , Breakthrough Device Designations , High Tech Campus , Media Enquiries , Investor Enquiries , Wonward , Medical , Reports , 021 , Bull , Ear , Financial , Operating , Results ,